Abstract:Abstract Demand for new technologies that deliver fast, inexpensive and accurate genome information has never been greater. This challenge has catalysed the rapid development of advances in next-generation sequencing (NGS). The generation of large volumes of sequence data and the speed of data acquisition are the primary advantages over previous, more standard methods. In 2013, the Food and Drug Administration granted marketing authorisation for the first high-throughput NG sequencer, Illumina’s MiSeqDx, which allowed the development and use of a large number of new genome-based tests. Here, we present a review of template preparation, nucleic acid sequencing and imaging, genome assembly and alignment approaches as well as recent advances in current and near-term commercially available NGS instruments. We also outline the broad range of applications for NGS technologies and provide guidelines for platform selection to best address biological questions of interest. DNA sequencing has revolutionised biological and medical research, and is poised to have a similar impact on the practice of medicine. This tool is but one of an increasing arsenal of developing tools that enhance our capabilities to identify, quantify and functionally characterise the components of biological networks that keep us healthy or make us sick. Despite advances in other ‘omic’ technologies, DNA sequencing and analysis, in many respects, have played the leading role to date. The new technologies provide a bridge between genotype and phenotype, both in man and model organisms, and have revolutionised how risk of developing a complex human disease may be assessed. The generation of large DNA sequence data sets is producing a wealth of medically relevant information on a large number of individuals and populations that will potentially form the basis of truly individualised medical care in the future.

Review of applications of high-throughput sequencing in personalized medicine: barriers and facilitators of future progress in research and clinical application

High‐throughput sequencing for biology and medicine

The Principles and Applications of High-Throughput Sequencing Technologies

Transforming Clinical Research: The Power of High-Throughput Omics Integration

Next-generation sequencing technologies: breaking the sound barrier of human genetics

Bioinformatics and personalized medicine in the U.S.: A comprehensive review: Scrutinizing the advancements in genomics and their potential to revolutionize healthcare delivery

Critical role of bioinformatics in translating huge amounts of next-generation sequencing data into personalized medicine

State-of-the-Art Technologies to Interrogate Genetic/Genomic Components of Drug Response

The use of next-generation sequencing in personalized medicine

Next-generation sequencing in the clinic: Promises and challenges

High Throughput Sequencing Advances and Future Challenges

New-generation high-throughput technologies based 'omics' research strategy in human disease]

Advancing Personalized Medicine Through the Application of Whole Exome Sequencing and Big Data Analytics

High‐throughput molecular assays for inclusion in personalised oncology trials – State‐of‐the‐art and beyond

Bioinformatic Challenges Detecting Genetic Variation in Precision Medicine Programs

Barriers and facilitators to next-generation sequencing use in United States oncology settings: a systematic review

Advances in the Clinical Application of High-throughput Proteomics

The application of long-read sequencing in clinical settings

From DNA to Data: Transcending Beyond the Double Helix and Demystifying the Genetic Alchemy of Life Through NGS to Empower Precision Medicine

High-throughput sequencing and clinical microbiology: progress, opportunities and challenges

The Application of Long-Read Sequencing to Cancer